Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2008
03/19/2008EP1900726A1 Heterocyclic thioesters
03/19/2008EP1900368A1 Tablet containing hardly soluble active ingredient
03/19/2008EP1900363A1 Therapeutic agent for pain
03/19/2008EP1900362A2 Alfa-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
03/19/2008EP1900360A1 Homer a new target of treating psychiatric disorders
03/19/2008EP1899377A2 Humanised antibodies specific for nogo-a and phrarmaceutical uses thereof
03/19/2008EP1899350A1 Pyrazolo ý3 , 4-d¨azepine derivatives as histamine h3 antagonists
03/19/2008EP1899343A1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
03/19/2008EP1899339A1 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel
03/19/2008EP1899333A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
03/19/2008EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
03/19/2008EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
03/19/2008EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
03/19/2008EP1899303A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1899301A1 Novel 3-aza-spiroý5.5¨undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1899294A1 Therapeutic agents
03/19/2008EP1898947A2 Botulinum toxin and the treatment of primary disorders of mood and affect
03/19/2008EP1898915A2 Combinations of eszopiclone and an antidepressant, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
03/19/2008EP1898908A2 Novel chemical compounds and the uses thereof as a medicament
03/19/2008EP1898906A2 Methods of treatment utilizing certain melatonin derivatives
03/19/2008EP1898905A2 Hydroisoindoline tachykinin receptor antagonists
03/19/2008EP1898895A2 Treatment of drug abuse
03/19/2008EP1898722A2 Polar lipid mixtures, their preparation and uses
03/19/2008EP1720544B1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
03/19/2008EP1696905B1 Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
03/19/2008EP1654241B1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
03/19/2008EP1636223B1 Benzothiazole derivatives as adenosine receptor ligands
03/19/2008EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
03/19/2008EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
03/19/2008EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects
03/19/2008EP1469848B1 Sedative non-benzodiazepine formulations
03/19/2008EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS
03/19/2008EP1429792B1 Strontium compound for treatment of sub-dermal soft tissue pain
03/19/2008EP1423103A4 Compositions and methods for modulation of darpp-32 phosphorylation
03/19/2008EP1399450B1 Benzoxazepine derivatives and their use as ampa receptor stimulators
03/19/2008EP1363630B1 Kappa opioid receptor ligands
03/19/2008EP1362031B1 Pharmaceutically active piperidine derivatives
03/19/2008EP1296970B1 Method for the preparation of citalopram
03/19/2008EP1196083B1 Imaging the dopamine transporter to determine ad-hd
03/19/2008EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/19/2008EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
03/19/2008EP0594669B9 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
03/19/2008CN101146809A Process for preparing quinoline compounds and products obtained therefrom
03/19/2008CN101146800A Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
03/19/2008CN101146790A 2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som cgrp-antagonister
03/19/2008CN101146787A Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
03/19/2008CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
03/19/2008CN101146775A Metabolites for nk-i antagonists for emesis
03/19/2008CN101146541A Method and composition for treating central nervous system disorders
03/19/2008CN101146539A Use of pde7 inhibitors for the treatment of neuropathic pain
03/19/2008CN101146521A Oral drug delivery system supplying coatings containing cellulose and methyl propenoic acid deritives
03/19/2008CN101143867A Antidepressant indolealkyl derivatves of heterocyclefused benzodioxan methylamines
03/19/2008CN101143217A Treatment of neurological and neuropsychological disorders
03/19/2008CN101143208A Sobering-up liver-protecting capsule and production method thereof
03/19/2008CN101143192A Therapeutic gastrodia extracts
03/19/2008CN101143187A Traditional Chinese medicine preparation capable of tranquilizing and heart and depression relieving
03/19/2008CN101143183A Traditional Chinese medicine for treating intractable headache
03/19/2008CN101143182A Traditional Chinese medicine for treating alcoholic cirrhosis
03/19/2008CN101143181A Traditional Chinese medicinal composition for treating senile dementia and preparation method and application thereof
03/19/2008CN101143168A Technology for preparing haw total phenolic acid part
03/19/2008CN101143157A Tyrosol and tyrosol bypass salidroside plant extraction and preparation and use thereof
03/19/2008CN101143147A Sapogenin derivatives and their use in the treatment of cognitive dysfunction
03/19/2008CN101143136A Paroxetine slow release micropills preparation
03/19/2008CN101143135A Melatonin orally disintegrating tablet and preparation method thereof
03/19/2008CN100375746C Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method
03/19/2008CN100375630C Compound drop pills with flavescent sophora root and its preparation method
03/19/2008CN100375626C Chinese medicine compound preparation for treating depression and its preparation method
03/19/2008CN100375619C Medicinal compositions improving brain function and method for improving brain function
03/19/2008CN100375608C Tortoise-astragalus root-ginseng dripping pill and its preparing method
03/18/2008US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
03/18/2008US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
03/18/2008US7345065 Using adrenergic receptors; side effect reduction
03/18/2008US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity
03/18/2008US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/18/2008US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders
03/18/2008US7345041 Chemical compounds
03/18/2008US7345038 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
03/18/2008US7345036 (Pyrido/thieno)—[f]—oxazepine-5-one derivatives
03/18/2008CA2454328C Pharmaceutical combinations of oxycodone and naloxone
03/18/2008CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
03/18/2008CA2347195C Oral pharmaceutical compositions containing buprenorphin
03/18/2008CA2345248C Use of prostanoid antagonists for the treatment of primary headache disorders
03/18/2008CA2335015C Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
03/18/2008CA2327784C Triazolones with a neuroprotective action
03/18/2008CA2323839C Treatment of neuropathy
03/18/2008CA2189145C Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
03/13/2008WO2008030651A1 Combinations containing a 4-acylaminopyridine derivative
03/13/2008WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
03/13/2008WO2008030251A1 Deglycosylated anti-amyloid beta antibodies
03/13/2008WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity
03/13/2008WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient
03/13/2008WO2008029871A1 Nerve fiber degeneration inhibitor
03/13/2008WO2008029836A1 Study, determination or evaluation method
03/13/2008WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient
03/13/2008WO2008029825A1 Imidazole derivative
03/13/2008WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
03/13/2008WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action
03/13/2008WO2008029493A1 Nerve fiber degeneration inhibitor
03/13/2008WO2008029167A1 Method of treating peripheral nerve disorders
03/13/2008WO2008028958A1 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
1 ... 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 ... 1833